We observed that the treatment with nintedanib, pirfenidone and D + Q were able to reduce the levels of cathepsin B in IPF senescent lung fibroblast (Fig. 7c), while no significant difference was observed in the normal group. The gene discussed is CTSB; the disease is idiopathic pulmonary fibrosis.